BioNTech SE American Depositary Share (BNTX) Stock Price

BNTXStock

$114.05+1.75%52W

Market Cap$28.65B

P/E—

PEG Ratio0.05

Div yield—

Beta1.27

BNTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-6.73%

Price vs S&P 500 (4W)18.98%

PEG Ratio0.05

VGM Score52.81

P/CF (Annual)55.05x

Book Value / Share (Quarterly)$82.49

P/TBV (Annual)1.11x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-45.07%

Cash Flow / Share (Quarterly)$2.07

Payout Ratio (TTM)17.60%

Price vs S&P 500 (YTD)6.55%

Gross Margin (TTM)79.23%

Net Profit Margin (TTM)-63.64%

EPS (TTM)$-7.83

10-Day Avg Trading Volume2.13M

EPS Excl Extra (TTM)$-7.83

Revenue Growth (5Y)42.88%

EPS (Annual)$-5.49

Dividend / Share (Annual)$0.00

ROI (Annual)-5.83%

Gross Margin (Annual)84.37%

Net Profit Margin (5Y Avg)13.87%

Cash / Share (Quarterly)$68.66

Revenue Growth QoQ (YoY)-23.75%

ROA (Last FY)-5.17%

Revenue Growth TTM (YoY)-11.81%

EBITD / Share (TTM)$-6.22

ROE (5Y Avg)25.77%

Operating Margin (TTM)-75.31%

Cash Flow / Share (Annual)$-1.36

P/B Ratio1.41x

P/B Ratio (Quarterly)1.14x

Net Income / Employee (Annual)$-169,797

EV / Revenue (TTM)5.92x

Net Interest Coverage (TTM)-1.43x

ROA (TTM)-7.96%

EV / EBITDA (TTM)19.22x

EPS Incl Extra (Annual)$-5.49

Current Ratio (Annual)7.54x

Quick Ratio (Quarterly)7.80x

3-Month Avg Trading Volume1.09M

52-Week Price Return1.75%

EV / Free Cash Flow (Annual)0.88x

Revenue / Employee (TTM)$396,075

Tangible BV / Share (Quarterly)$75.89

P/S Ratio (Annual)8.75x

Asset Turnover (Annual)0.13x

52-Week High$144.71

Operating Margin (5Y Avg)14.98%

EPS Excl Extra (Annual)$-5.49

CapEx CAGR (5Y)54.53%

Tangible BV CAGR (5Y)69.43%

26-Week Price Return4.51%

Quick Ratio (Annual)7.49x

13-Week Price Return24.07%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)7.85x

Enterprise Value$18.30B

Revenue / Share Growth (5Y)44.19%

Asset Turnover (TTM)0.13x

Book Value / Share Growth (5Y)68.27%

Revenue / Employee (Annual)$428,984

Inventory Turnover (Annual)2.28x

Pretax Margin (Annual)-36.61%

Cash / Share (Annual)$69.08

3-Month Return Std Dev52.24%

Gross Margin (5Y Avg)84.18%

Net Income / Employee (TTM)$-252,069

ROE (Last FY)-5.91%

Net Interest Coverage (Annual)12.06x

EPS Basic Excl Extra (Annual)$-5.49

P/FCF (TTM)22.70x

Receivables Turnover (TTM)3.42x

EV / Free Cash Flow (TTM)35.26x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-7.83

Receivables Turnover (Annual)2.39x

ROI (TTM)-8.96%

P/S Ratio (TTM)9.47x

Pretax Margin (5Y Avg)24.79%

Revenue / Share (Annual)$13.86

Tangible BV / Share (Annual)$81.81

Price vs S&P 500 (52W)-16.56%

Year-to-Date Return18.51%

5-Day Price Return21.64%

EPS Normalized (Annual)$-5.49

ROA (5Y Avg)20.29%

Net Profit Margin (Annual)-39.59%

Month-to-Date Return24.55%

Cash Flow / Share (TTM)$15.18

EBITD / Share (Annual)$-4.94

Operating Margin (Annual)-48.97%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)36.93x

ROI (5Y Avg)25.26%

LT Debt / Equity (Quarterly)0.01x

EPS Basic Excl Extra (TTM)$-7.83

P/TBV (Quarterly)1.23x

Payout Ratio (Annual)5.13%

P/B Ratio (Annual)1.02x

Inventory Turnover (TTM)3.32x

Pretax Margin (TTM)-61.49%

Book Value / Share (Annual)$89.26

Price vs S&P 500 (13W)21.28%

Beta1.27x

P/FCF (Annual)5.38x

Revenue / Share (TTM)$12.21

ROE (TTM)-9.10%

52-Week Low$92.80

vGradeC

gGradeC

mGradeB

vgmGradeC

BNTX Earnings Surprise History

Q2 25-1.87est. -1.64

Q3 25-0.14est. 0.12

Q4 25-0.39est. -0.30

Q1 26-2.28est. -2.24

Q2 26-2.59est. -2.43

BNTX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.04

4.00

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	$14.56

About BioNTech SE American Depositary Share

BioNTech is a German biotechnology company developing mRNA-based cancer immunotherapies and vaccines for infectious diseases. Its oncology pipeline includes multiple therapeutic modalities such as mRNA drugs, cell therapies, bispecific antibodies, and antibody-drug conjugates. The company's first commercialized product is Comirnaty, a COVID-19 vaccine developed in partnership with Pfizer.